Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants

• Autores principales: Tatsuhiko Ozawa (Autor), Hideki Tani (Autor), Yuki Anraku (Autor), Shunsuke Kita (Autor), Emiko Igarashi (Autor), Yumiko Saga (Autor), Noriko Inasaki (Autor), Hitoshi Kawasuji (Autor), Hiroshi Yamada (Autor), so-Ichiro Sasaki (Autor), Mayu Somekawa (Autor), Jiei Sasaki (Autor), Yoshihiro Hayakawa (Autor), Yoshihiro Yamamoto (Autor), Yoshitomo Morinaga (Autor), Nobuyuki Kurosawa (Autor), Masaharu Isobe (Autor), Hideo Fukuhara (Autor), Katsumi Maenaka (Autor), Takao Hashiguchi (Autor), Hiroyuki Kishi (Autor), Isao Kitajima (Autor), Shigeru Saito (Autor), Hideki Niimi (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Many potent neutralizing SARS-CoV-2 antibodies have been developed and used for therapies. However, the effectiveness of many antibodies has been reduced against recently emerging SARS-CoV-2 variants, especially the Omicron variant. We identified a highly potent SARS-CoV-2 neutralizing antibody, UT2...